1Y Annualised Return
▲41.39%
3Y Annualised Return
▲48.76%
5Y Annualised Return
▲37.35%
10Y Annualised Return
▲17.83%
Fortis Healthcare Stock Performance
|
|
|
Fortis Healthcare Company background
Fortis Healthcare Overview
Fortis Healthcare Limited was incorporated on February 28, 1996, by the Singh brothers as an extension of their pharmaceutical legacy. The company is headquartered at the Fortis Memorial Research Institute in Gurgaon, with its registered office in Mohali, Punjab. It operates 36 healthcare facilities across India, Dubai, and Sri Lanka, offering a range of medical services. Fortis is listed on both the Bombay Stock Exchange (BSE: 532843) and the National Stock Exchange (NSE: FORTISEQ), and is backed by Malaysia’s IHH Healthcare.
Fortis Healthcare Business Segments and Revenue Model
Fortis Healthcare operates through three primary segments: hospitals, diagnostics, and pharmacies. The hospital division provides multi-specialty tertiary and quaternary care services including cardiology, oncology, orthopaedics, neurology, and more. The diagnostics arm, Agilus Diagnostics, offers pathology and imaging services through a broad network. Its pharmacy business supports the hospital ecosystem and generates additional retail revenue. The company earns primarily through inpatient and outpatient services, diagnostics, pharmacy sales, and day-care procedures. Medical tourism contributes to the revenue as international patients seek cost-effective, high-quality treatment across Fortis facilities.
Fortis Healthcare Key Milestones
- 1996: Incorporated and launched its first hospital in Mohali, Punjab
- 2005: Acquired Escorts Heart and Research Centre in Delhi
- 2007: Launched its IPO and got listed on BSE and NSE
- 2015: Fortis Hospital Noida won the National Energy Conservation Award
- 2015: Received the Golden Globe Tigers Award for patient safety initiatives
- 2018: Founders resigned amid financial issues; IHH Healthcare acquired a 31.1% stake
- 2019: Acquired RHT Health Trust assets worth approximately ₹4,650 crore
- 2023: Completed acquisition of Medeor Hospital in Manesar
- 2024: Announced acquisition of a 31% stake in Agilus Diagnostics
- 2025: Won seven International Medical Value Travel Awards for excellence in various specialties
Fortis Healthcare ESG and Sustainability
- Tracks energy and water usage across hospitals with 19 active efficiency initiatives
- Focuses on eco-friendly biomedical waste management and carbon footprint reduction
- Implements WHO surgical safety protocols to enhance patient care
- Each unit has designated ESG champions driving sustainable practices
- Long-term goal includes embedding sustainability into core operations by 2030
Fortis Healthcare Awards and Recognitions
- Won the Golden Globe Tigers Award for excellence in patient safety practices
- Received the National Energy Conservation Award for energy efficiency at the Noida hospital
- Honoured at the International Patient Safety Conference for innovation and leadership
- Secured seven awards at the Medical Value Travel Summit across key specialties like cardiology, oncology, and orthopaedics
Fortis Healthcare Financial Highlights
Fortis Healthcare Share Price Today
Fortis Healthcare Fundamental
Market Cap (in crs)
66,572.21
Face Value
10
Turnover (in lacs)
7,651.48
Key Metrics
Fortis Healthcare Key Financials
View more2265.01 Cr | 2331.44 Cr | 2166.72 Cr | 2007.2 Cr | 1928.26 Cr |
7849.69 Cr | 6931.17 Cr | 6359.35 Cr | 5744.95 Cr | 4076.68 Cr | 4684.96 Cr |
193.87 Cr | 325.14 Cr | 263.86 Cr | 183.38 Cr | 252.24 Cr |
797.86 Cr | 635.71 Cr | 611.15 Cr | 765.8 Cr | -103.73 Cr | 79.32 Cr |
Fortis Healthcare Result Highlights
Result Summary
-
Fortis Healthcare Ltd reported a 3.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.6%.
-
Its expenses for the quarter were up by 0.5% QoQ and 15.9% YoY.
-
The net profit decreased 40.0% QoQ and decreased 22.4% YoY.
-
The earnings per share (EPS) of Fortis Healthcare Ltd stood at 2.57 during Q3 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Fortis Healthcare Technical Analysis
Delivery Volume %
Day
55.90%
Week
57.90%
Month
49.70%
Delivery & Volume
Day Rs | 497428 Rs | 889372 Rs |
Week Rs | 790593 Rs | 1365990 Rs |
Month Rs | 818139 Rs | 1647276 Rs |
Resistance & Support
Fortis Healthcare Peer comparison
Compare7,803.00 +24.00 (+0.31%)▲ | |
1,750.50 -7.70 (-0.44%)▼ | |
665.50 +7.20 (+1.09%)▲ | |
1,043.10 +1.60 (+0.15%)▲ | |
688.50 -4.55 (-0.66%)▼ | |
1,105.20 +15.50 (+1.42%)▲ |
Fortis Healthcare Latest News
Fortis Healthcare Ltd - 532843 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 ('SEBI Listing Regulations') Regarding A Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan.
Fortis Healthcare Share Price FAQs
Please be aware that Fortis Healthcare stock prices are subject to continuous fluctuations due to various factors.